A detailed history of Harbour Investment Management LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Harbour Investment Management LLC holds 37,440 shares of BMY stock, worth $2.18 Million. This represents 0.87% of its overall portfolio holdings.

Number of Shares
37,440
Previous 34,185 9.52%
Holding current value
$2.18 Million
Previous $1.42 Million 36.5%
% of portfolio
0.87%
Previous 0.66%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$39.66 - $51.75 $129,093 - $168,446
3,255 Added 9.52%
37,440 $1.94 Million
Q2 2024

Jul 22, 2024

BUY
$40.25 - $52.99 $36,828 - $48,485
915 Added 2.75%
34,185 $1.42 Million
Q1 2024

May 08, 2024

BUY
$47.98 - $54.4 $402,552 - $456,416
8,390 Added 33.72%
33,270 $1.8 Million
Q4 2023

Feb 09, 2024

SELL
$48.48 - $57.85 $142,046 - $169,500
-2,930 Reduced 10.54%
24,880 $1.28 Million
Q3 2023

Nov 14, 2023

SELL
$57.89 - $64.73 $5,789 - $6,473
-100 Reduced 0.36%
27,810 $1.61 Million
Q2 2023

Aug 11, 2023

SELL
$63.71 - $70.74 $3,185 - $3,536
-50 Reduced 0.18%
27,910 $1.78 Million
Q1 2023

May 12, 2023

BUY
$65.71 - $74.53 $186,944 - $212,037
2,845 Added 11.33%
27,960 $1.94 Million
Q4 2022

Feb 10, 2023

BUY
$68.48 - $81.09 $20,544 - $24,327
300 Added 1.21%
25,115 $1.81 Million
Q3 2022

Nov 15, 2022

BUY
$0.13 - $76.84 $130 - $77,224
1,005 Added 4.22%
24,815 $1.76 Million
Q2 2022

Aug 15, 2022

SELL
$72.62 - $79.98 $87,144 - $95,976
-1,200 Reduced 4.8%
23,810 $1.83 Million
Q1 2022

May 16, 2022

SELL
$61.48 - $73.72 $33,875 - $40,619
-551 Reduced 2.16%
25,010 $1.83 Million
Q4 2021

Feb 14, 2022

BUY
$53.63 - $62.52 $137,882 - $160,738
2,571 Added 11.18%
25,561 $1.59 Million
Q3 2021

Nov 15, 2021

BUY
$59.17 - $69.31 $1.36 Million - $1.59 Million
22,990 New
22,990 $1.36 Million

Others Institutions Holding BMY

About BRISTOL MYERS SQUIBB CO


  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $124B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Harbour Investment Management LLC Portfolio

Follow Harbour Investment Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Harbour Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Harbour Investment Management LLC with notifications on news.